IONSPEC
CLINICAL TEST REPORT
FINAL STAGE (15 DEC 2012-30 DEC 2013)
Researchers Profile:
1. Professor Dr.Chu Yun Sang. PPN. PJK. President of Taipei TCM Medical Centre Sdn. Bhd.
Selangor, Malaysia. United States Golden University, Doctor of Philosophy. BSc(TCM).
2. Saw Lay San. Research Conductor, Taipei TCM Medical Centre Sdn.Bhd. Selangor,
Malaysia. University of Lethbridge, Canada.Bio-Psychological Science Study. Su-Chen TCM
Clinic Trail, Manitoba, Canada. PPL Canada, CPL(T) Malaysia.
ABSTRACT:
The primary goals of the studies are to verify the effectiveness of negative IonSpec could help to
improve visual acuity in the subject study. This test is to study non-side effect of the negative
IonSpec. The causes for vision problems in the population are: Aging and macular
degeneration. Visual problems are aging-associated eye problems. Early prevention with
antioxidants is mandatory. This study is to suggest negative IonSpec acts as source of
antioxidant.
Introduction:
Our ideology is to induce bodily naturally rejuvenation functionalities, which including vision.
Our approach is non intervention (non-surgical) method. In conjunction of Negative Ions could
help eyes cells rejuvenation and lead to restoration of eyes functions. Therefore, we were
measuring the vision improvement after using Negative IonSpec( IonSpec,2011) .
The causes for vision problems in the population are: Aging and macular degeneration.
Visual problems such as: Asthenopia, myopic, astigmatism, presbyopia, cataract and age-related
macular degeneration can lead to severe central vision loss (Sheedy, Hayes ,Engle ,2003).
In glaucoma, researchers believe that the ganglion cells of the retina, as well as the support cells
within the optic nerve, can die for various reasons. Some possible reasons include excessive fluid
pressure within the eye, and lack of blood flow or oxygen. With sufficient damage, sight is lost. Damage
to the optic nerve is irreversible because the cable of nerve fibres doesn’t have the capacity to
regenerate, or heal itself, when damage occurs. This is why glaucoma is an incurable disease at this
point, and why early detection is so important. ( Benowitz,2011).
However, we had suggested the negative ions spec could give aid if glaucoma had detected in
early stage. Our negative Ions spec had shown vision improvement and maintaining effect for one
glaucoma patient. Suggest that the negative ions increase the flow of oxygen to the brain, which
improved our patients vision (Taipei Medic,Malaysia, 2013).
Dr.Pierce J. Howard, Dr. Phillip E.A. Lennard, and Dr. Jacob (B) agreed that negative ions have
unique benefits to human body. Which negative ions increase the flow of oxygen to the brain; resulting
in higher alertness, decreased drowsiness, and more mental energy. ( Howard, 2006) . Negative ions
help recovery from physical exhaustion and fatigue – achieved by increasing oxygen levels in the blood.
Negative ions promote cell rejuvenation by revitalizing cell metabolism (Iriswellbeing,2010).
Negative Ions improves visual sharpness (acuity) and reduces the incidence of
blindness caused by lack of oxygen. Beside, negative ions improve retinal blood flow and
circulation. Negative ions could reduce swelling in eyes vassals and thereby the risk of
developing glaucoma and cataract.
The macula area of the retina and optic nerve fibres is fragile to oxygen deficiency.
These fibres and nerves cells require from four to six times as much Oxygen and nutrition
and the visual pathways peripheral nerves. These fibres and nerves (Tods & Cones) cannot
function without Oxygen for more than 90 seconds without some visual loss (Martini &
Hum,2008).
Dr Bates, an ophthalmologist, stopped prescribing glasses to his clients after observed that their
visual problems like: nearsightedness, farsightedness, astigmatism, presbyopia and lazy eye, got
progressively worse after wearing the glasses. He theorized that the glasses stopping the eyes from
healing itself naturally (Quakenbush,2000). Prescription glasses cause lots of strain and stress to
patient’s vision system. The strain caused by these glasses is the major contributing factors to patient’s
eyes problems ( Quakenbush,2000).
Subjects Selection:
12 subjects ranging from 10 to 80 years of age with one or more of the following visual problems
were recruited from Taipei T&CM Medical Centre, Selangor, Malaysia:
a) Asthenopia and/or subjective levels of computer vision syndrome.
b) Myopes , with low refractive error, which could include astigmatism.
c) Hyperopes and beginning presbyopes who were using their reading glasses
d) Presbyopia, hyperopia, and/or other vision problems.
And, whom with ocular pathology example: diabetes, glaucoma, cataract, and macular
degeneration.
Subjects Grouping:
Grouping (Experimental, A-D) Subjects
A. Patients with minor or minimum eye's 1. F, 40
diseases: 2. F, 61
3. F,35
B. Patients with middle stage of eye's 1. M, 55
diseases 2. F, 10
3. F,46
4. M,64, Glaucoma
5. M,70
6. M,33
C. Patients with chronic stage eye's diseases 1. M, 75 , Glaucoma
or 2. F, 50
D. Patient, blind. F,58
E. Control Group, patient no using Neg F, 33
IonSpec
Result Capture Method:
Individual's vision acuity or stated vision problems were measured (2). The parameter is
visual acuity of participant subjects. A Snellen chart or equipment was used to measured
subjects visions. Second parameter is by observation of subject’s behaviour and/or by interviews
to determinate vision changes.
Third parameter is testimonial given by the patients before and after using negative IonSpec.
Research subjects are divided into four major groups as listed: Group A) Patients with minor or
minimum eye's diseases: Purpose to verify the Negative IonSpec is safe, non-side effects. After 1
year of wearing Negative IonSpec that majority subjects would not have visual deteriorate then
the before the study. Hence, subject’s visual acuity should be category in healthy stage before the
study.
Result:
Group A: right eye visual acuity improvement (%) versus time (weeks):
Group A: Right eye astigmatism improvement (%) versus time (weeks):
Group A: Left eye visual acuity improvement (%) versus time (weeks):
Group A: Left eye astigmatism improvement (%) versus time (weeks):
Discussions:
Subject A 1(F,40): SPH(S) CYL(C ) AX
R -1.5 -0.5 29
L -0.75 -0.5 124
Date:2nd Dec 2012
R -1.25 -0.5
L -0.5 -0.25 7th March 2013
After 3 months using negative IonSpec, patient’s right eyes have improving by 16% on
visual acuity test. Patient’s Left eye vision acuity test improving by 33%. On the astigmatism
right eye remain the same, but left eye’s improving by 50%.
R -1.25 -0.25
L -0.50 -0.50 15th Dec 2013
After 12 months of using negative Ion Spec, patient’s right and left eye vision acuity maintaining
after the first 3 moths of improvement. Right eye astigmatism improved by 50%.But, left eye
astigmatism reversing by 50%. Suggest this is a temporary adjustment as this observation has
occurs in other patients whom using the same product. Overall improvement has maintained after
12 months as compared to before using negative Ions spec.
--------------------------------------------------------------------------------------------------------------------
-
Subject: A2( F, 61)
Visual problems: Mild Myopia, mild Presbyopia/Hyperopia
S C
R +0.37 -0.50 120
S.E.+0.12
L +1.12 -1.25 20
S.E.+0.5 16th Dec 2012
After 3 months of using Negative IonSpec,Test result on her vision : her visual acuity has
improves by 22% on her left eye. Right eye visual acuity under neurological transitions,
improves 50%.
S C
R - 0.12 -0.37 130
+0.00 -0.25 125
S.E. -0.12
L +0.87 -0.87 20
S.E. +0.37 26th Feb 2013
Patient testing her eyes on other equipment:
S C
R +0.25 -0.50 100
S.E. +0.00
S C
L +1.25 -1.0 15
S.E. +0.75
After 5 months, A2 right eye visual acuity improves by 32%. Astigmatism reversed back by
35%. A2 left eye visual acuity reversed back by 11%. Astigmatism improving by 20%
Date: 8th/May 2013 Patient’s left eyes
R +0.5 0.00
L +1.375 -1.125 12th Dec 2013
After 1 year, A2 right eye visual acuity reversed back 13%, but astigmatism has gone.
------------------------------------------------------------------------------------------------------------------
A3, F, 35. Used IonSpec two to three weeks, her myopia dropped from 0.5 to 0.25. Followed
with 12 months continued wearing, maintaining visual acuity.
------------------------------------------------------------------------------------------------------------------
Result:
Group B : Visual acuity improvement (%) versus time (week).
Group B) Patients with middle stage of eye's diseases: IonSpec can help with vision or eye's
sight improvement.
Discussions:
Subject B1, M,55: Subject with complex visual problems (due to accident impact on his eye):
Myopic vision has improved 10% in the beginning of 2 weeks ( 30th Dec 2012). He reported
having clear vision after 3 months wearing IonSpec, equivalents of 50% vision improvement.
His asthenopia(1),glare, blurred vision, floaters has reduced. Suggest that he still experiencing
neurological transition, where his myopic problem mildly reduce to beginning stage (measured
by Snellen chart). But floaters were gone. Therefore, overall vision has improved as his
statement was provided by interview.
4.9 can read clearly on Snelle Chart. 11th April 2013.
4.9 can read clearly on Snelle Chart. 13th May 2013.
Subject B2, F,10. Myopic. She had eye examination from Optometrist located in Ipoh. Before
treatment:
R -350
L -450 5th Dec 2012
R -325
L -450 5th May 2013
After 7 months of using negative Ions spec: her mother brought her back for follow up, as her
eye sight improved (7%) on the right side. Her left eye remain the same, no improvement. 13 th
July 2013
--------------------------------------------------------------------------------------------------------------------
-
B3, F,46. Test on Snelle Chat .12th March 2013. After 1 month wearing negative ionSpec.
Improvement 4.5% on 17th April 2013. Maintaining 4.4 can read. 10th May 2013.
B4, M, 63. Glaucoma.
RX(R) : +3.75 DS -1.50 DC X85 3rd Dec 2012
Snelle Chart 4.8 can read. 4.9 Can not read. 30th Dec 2012
Visual acuity (R): 6/18
RX(R) +3.25 DS -1.75 DC X 100 Pupil Diameter: 4.8mm
Visual acuity (L):6/9 Pupil Diameter : 4.1mm
RX(L) +3.50 DS -1.50 DC X100 3th April 2013
RX (R) :+3.25 DS -1.75 DC X 100 Pupil Diameter: 5.9mm
Visual acuity( R) : 6/9
RX (L) : +3.25 DS- 1.50 DC X100 Pupil diameter : 4.2 mm
Visual acuity (L): 6/9 7th Sept 2013
Patient’s visual system is undergoing some adjustment after wearing Negative IonSpec since 3rd
December 2012. His RX values was adjusting from +3.75 to +3.25. From -1.50 to -1.75. After
that, visual acuity field has improved steady: Patient’s visual acuity has improved from 6/18 to
6/9 ( 50%) on his right eye, after 8 months wearing negative Ions specs, together herbal and
complimentary treatments.
--------------------------------------------------------------------------------------------------------------------
-
B5, M,70. I wear the IonSpec 3 and a half months- after my presbyopia reduced 75 (the original
275 , 200 now)(( improvement 27%)). There, my floaters previous daily stop now rarely. Before
using negative IonSpec, I can read newspapers about half an hour and felt tire on eyes. But, after
wearing negative IonSpec,I could reads several hours, my eyes will not feel tired. Further, I
could drives, and not feel fatigue. Thank you. 5th Dec 2013.
--------------------------------------------------------------------------------------------------------------------
-
B6, M, 33. Start using IonSpec on September 2011. Vision problem: myopic, and astigmatism.
After 5 weeks of using IonSpec, subject report blurry vision. The subject went for another eyes
test, his vision has improved:
Before using IonSpec:
S C
R -450 -50
L -400 -50 Sept 2011
After 5 weeks of using IonSpec ,
R -400 0
L -375 0 10th Oct 2011
Since then, subject vision has maintained as stated. Subject has been reading on computer, and
cell phone, the reasons that subject doubt in for vision improvement. 16th July, 2013.
Eyes treatment has started on October. 17th July 2013.
------------------------------------------------------------------------------------------------------------------
Group C) Patients with chronic stage eye's diseases:
Result:
Subject C1:M, 80. Vision 2-10%, advance stage glaucoma.
His eye pressure had reduced after 3 weeks of wearing Negative Ions Spec, together with
acupuncture, herbal treatment.
C2, F,50 .
S C
R -10.00 -3.00
L -10.00 -3.00 15th May 2012
After 2 months using Neg Ions Spec:
S C
R -8.00 -2.00
L -8.00 -1.50 17th July 2012
Group D1,patient who are blind:
Subject: F,58.
A blind patient started using negative Ion Spec on 31st Dec 2012.
Group E1,F,33. Patient as Control group, Not Using negative IonSpec. Her vision problem is
moderation of astigmatism.
S C
R - 4.00
L - 3.50 10th Jan 2013
After 1 year, her astigmatism remains the same, no improvement. 16th Dec 2013
Conclusion: Ten subjects(who wears negative IonSpec) expressed satisfaction; their vision
improvement with the Negative Ions Spec provided. The results of the evaluation suggest that the
effectiveness of negative IonSpec could help to improve visual acuity in the subjects. The control
group, who do not wear IonSpec, estimating their vision remain same or worsen after 3-6
months. Comparing the experimental groups (patients who wearing IonSpec) and control group
(Not-wearing IonSpec). Those experimental groups visual acuity has improved. Therefore, we
suggest IonSpec provided positive effects in helping patients vision.
Researchers Profile:
3. Professor Dr.Chu Yun Sang. PPN. PJK. President of Taipei TCM Medical Centre Sdn. Bhd.
Selangor, Malaysia. United States Golden University, Doctor of Philosophy. BSc(TCM).
4. Saw Lay San. Research Conductor, Taipei TCM Medical Centre Sdn.Bhd. Selangor,
Malaysia. University of Lethbridge, Canada.Bio-Psychological Science Study. Su-Chen TCM
Clinic Trail, Manitoba, Canada. PPL Canada, CPL(T) Malaysia.
Foot Notes:
A. Asthenopia: weakness or easy fatigue of the eye, with pain in the eyes, headache, dimness
of vision.
Reference:
1) http:// www.Ionspec.net , www.ionspeconline.com, www.Ionic.com.my
2) Sheedy JE, Hayes JN, Engle J.(2003,Nov). Is all asthenopia the same? Optometry &
Vision Science. 80(11):732-9. Columbus, Ohio. The Ohio State University, College of
Optometry. USA.
3) Larry Benowitz （ 2011 ， February 27 ） . Glaucoma Research Foundation. Director,
Laboratories for Neuroscience Research in Neurosurgery and Professor of Neurobiology
and Neurosurgery at Harvard Medical School, Children’s Hospital Department of
Neurosurgery, Boston,MA. Retrieved from http://www.glaucoma.org/research/optic-
nerve-regeneration-1.php
4) Pierce J. Howard( 2006,March). The Owners Manual for the Brain: Everyday
Applications from Mind Brain Research(p.695-697,812).
5) Iris Wellbeing Halotherapy Spa Waterloo,Ontario,Canada (2010)
http://www.iriswellbeing.com/negative_ions.html
6) Betty Martini, D.Hum (2008, Dec 31). National Federation of The Blind of Hawaii-
Aspatame and Vision. Mission Possible International. 9270 River Club Parkway Duluth,
Georgia 30079. Retrieved from http://www.wnho.net/nfb_aspartame_and_vision.htm
7) Thomas R. Quakenbush(2000).Batter Eye Sight. The complete magazines of William
H.Bates (p.xxiv,6, 23--). Bekerly, Carlifornia. North Atlantic Book.
8) Steven M. Beresford, David W. Muris, Mara Tableman, Francis A. Young (2005).
Clinical evaluation of the see clearly method. Retrieved from http://www.strong-
eyes.com/RESEARCH%20MASTER.pdf
9) Optometry & Vision Science. Retrieved from: https://journals.lww.com/optvis
10) Snellen Chart http://en.wikipedia.org/wiki/Snellen_chart
11) http://www.naturalvisioncenter.com/index.html (1983)
12) http://www.naturalvisiontherapy.com/
13)http://www.nlm.nih.gov/medlineplus/ency/article/003434.htm
14) http://www.selectspecs.com/info/help-with-prescription/
